These data argue for a dual regulation of NM23-H1 during tumor development and progression: overexpression of NM23-H1 can be detected in the primary tumor compared to the adjacent non tumoral tissue during early steps of tumorigenesis, and later a downregulation of NM23-H1 expression occurs during metastatic progression [28]. This evidence concerns the gene NME1 and neoplasm.